The DOI matches its Crossref record; 55 of the 55 references it cites were found in a registry or an index.
Intestinal antiinflammatory effect of 5-aminosalicylic acid is dependent on peroxisome proliferator–activated receptor-γ
Open accessAbstract
5-aminosalicylic acid (5-ASA) is an antiinflammatory drug widely used in the treatment of inflammatory bowel diseases. It is known to inhibit the production of cytokines and inflammatory mediators, but the mechanism underlying the intestinal effects of 5-ASA remains unknown. Based on the common activities of peroxisome proliferator–activated receptor-γ (PPAR-γ) ligands and 5-ASA, we hypothesized that this nuclear receptor mediates 5-ASA therapeutic action. To test this possibility, colitis was induced in heterozygous PPAR-γ+/− mice and their wild-type littermates, which were then treated with 5-ASA. 5-ASA treatment had a beneficial effect on colitis only in wild-type and not in heterozygous mice. In epithelial cells, 5-ASA increased PPAR-γ expression, promoted its translocation from the cytoplasm to the nucleus, and induced a modification of its conformation permitting the recruitment of coactivators and the activation of a peroxisome-proliferator response element–driven gene. Validation of these results was obtained with organ cultures of human colonic biopsies. These data identify PPAR-γ as a target of 5-ASA underlying antiinflammatory effects in the colon.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Yung-Chi, C., & Prusoff, W. H. (1973) · Biochemical Pharmacology · doi:10.1016/0006-2952(73)90196-2 · Cited by 12,922
Massagué, J. (1998) · Annual Review of Biochemistry · doi:10.1146/annurev.biochem.67.1.753 · Cited by 7,556
The nuclear receptor superfamily: the second decade
Mangelsdorf, D. J., Thummel, C., Beato, M., Herrlich, P., Schütz, G., Umesono, K., Blumberg, B., Kastner, P., Mark, M., Chambon, P., et al. (1995) · Cell · doi:10.1016/0092-8674(95)90199-x · Cited by 6,964
Development and validation of a genetic algorithm for flexible docking 1 1Edited by F. E. Cohen
Jones, G., Willett, P., Glen, R. C., Leach, A. R., & Taylor, R. (1997) · Journal of Molecular Biology · doi:10.1006/jmbi.1996.0897 · Cited by 6,763
Stimulation of adipogenesis in fibroblasts by PPARγ2, a lipid-activated transcription factor
Tontonoz, P., Hu, E., & Spiegelman, B. M. (1994) · Cell · doi:10.1016/0092-8674(94)90006-x · Cited by 3,529
The peroxisome proliferator-activated receptor-γ is a negative regulator of macrophage activation
Ricote, M., Li, A. C., Willson, T. M., Kelly, C. J., & Glass, C. K. (1998) · Nature · doi:10.1038/34178 · Cited by 3,525
Validation of the general purpose tripos 5.2 force field
Clark, M., Cramer, R. D., & Van Opdenbosch, N. (1989) · Journal of Computational Chemistry · doi:10.1002/jcc.540100804 · Cited by 2,812
Ligand binding and co-activator assembly of the peroxisome proliferator-activated receptor-γ
Nolte, R. T., Wisely, G. B., Westin, S., Cobb, J. E., Lambert, M. H., Kurokawa, R., Rosenfeld, M. G., Willson, T. M., Glass, C. K., & Milburn, M. V. (1998) · Nature · doi:10.1038/25931 · Cited by 1,958
PPAR-gamma: adipogenic regulator and thiazolidinedione receptor.
Spiegelman, B. M. (1998) · Diabetes · doi:10.2337/diabetes.47.4.507 · Cited by 1,730
Wang, R., Lai, L., & Wang, S. (2002) · Journal of Computer-Aided Molecular Design · doi:10.1023/a:1016357811882 · Cited by 1,191
The Organization, Promoter Analysis, and Expression of the Human PPARγ Gene
Fajas, L., Auboeuf, D., Raspé, E., Schoonjans, K., Lefebvre, A.-M., Saladin, R., Najib, J., Laville, M., Fruchart, J.-C., Deeb, S., et al. (1997) · Journal of Biological Chemistry · doi:10.1074/jbc.272.30.18779 · Cited by 1,188
Self-citationNeurath, M. F., Pettersson, S., Meyer Zum Büschenfelde, K.-H., & Strober, W. (1996) · Nature Medicine · doi:10.1038/nm0996-998 · Cited by 840
AN EXPERIMENT TO DETERMINE THE ACTIVE THERAPEUTIC MOIETY OF SULPHASALAZINE
Khan, A. K. A., Piris, J., & Truelove, S. C. (1977) · The Lancet · doi:10.1016/s0140-6736(77)90831-5 · Cited by 814
A novel therapy for colitis utilizing PPAR-γ ligands to inhibit the epithelial inflammatory response
Su, C. G., Wen, X., Bailey, S. T., Jiang, W., Rangwala, S. M., Keilbaugh, S. A., Flanigan, A., Murthy, S., Lazar, M. A., & Wu, G. D. (1999) · Journal of Clinical Investigation · doi:10.1172/jci7145 · Cited by 767
Gampe, R. T., Montana, V. G., Lambert, M. H., Miller, A. B., Bledsoe, R. K., Milburn, M. V., Kliewer, S. A., Willson, T. M., & Xu, H. E. (2000) · Molecular Cell · doi:10.1016/s1097-2765(00)80448-7 · Cited by 574
Xu, H. E., Lambert, M. H., Montana, V. G., Plunket, K. D., Moore, L. B., Collins, J. L., Oplinger, J. A., Kliewer, S. A., Gampe, R. T., McKee, D. D., et al. (2001) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.241410198 · Cited by 538
Oral 5-aminosalicylic acid for induction of remission in ulcerative colitis
Wang, Y., Parker, C. E., Bhanji, T., Feagan, B. G., & MacDonald, J. K. (2016) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd000543.pub4 · Cited by 494
Clark, R. B., Bishop-Bailey, D., Estrada-Hernandez, T., Hla, T., Puddington, L., & Padula, S. J. (2000) · The Journal of Immunology · doi:10.4049/jimmunol.164.3.1364 · Cited by 465
Desreumaux, P., Dubuquoy, L., Nutten, S., Peuchmaur, M., Englaro, W., Schoonjans, K., Derijard, B., Desvergne, B., Wahli, W., Chambon, P., et al. (2001) · The Journal of Experimental Medicine · doi:10.1084/jem.193.7.827 · Cited by 457
Self-citationSharon, P., Ligumsky, M., Rachmilewitz, D., & Zor, U. (1978) · PubMed · Cited by 451
Wallace, J. L., MacNaughton, W. K., Morris, G. P., & Beck, P. L. (1989) · Gastroenterology · doi:10.1016/0016-5085(89)90760-9 · Cited by 435
Impaired expression of peroxisome proliferator-activated receptor γ in ulcerative colitis
Dubuquoy, L., Jansson, E. Å., Deeb, S., Rakotobe, S., Karoui, M., Colombel, J.-F., Auwerx, J., Pettersson, S., & Desreumaux, P. (2003) · Gastroenterology · doi:10.1016/s0016-5085(03)00271-3 · Cited by 424
Self-citationBassaganya-Riera, J., Reynolds, K., Martino-Catt, S., Cui, Y., Hennighausen, L., Gonzalez, F., Rohrer, J., Benninghoff, A. U., & Hontecillas, R. (2004) · Gastroenterology · doi:10.1053/j.gastro.2004.06.049 · Cited by 393
Berger, J., Bailey, P., Biswas, C., Cullinan, C. A., Doebber, T. W., Hayes, N. S., Saperstein, R., Smith, R. G., & Leibowitz, M. D. (1996) · Endocrinology · doi:10.1210/endo.137.10.8828476 · Cited by 391
Role of Prostaglandins in Ulcerative Colitis
Sharon, P., Ligumsky, M., Rachmilewitz, D., & Zor, U. (1978) · Gastroenterology · doi:10.1016/s0016-5085(19)31672-5 · Cited by 388
Zhu, Y., Qi, C., Jain, S., Rao, M. S., & Reddy, J. K. (1997) · Journal of Biological Chemistry · doi:10.1074/jbc.272.41.25500 · Cited by 346
Interactions controlling the assembly of nuclear-receptor heterodimers and co-activators
Westin, S., Kurokawa, R., Nolte, R. T., Wisely, G. B., McInerney, E. M., Rose, D. W., Milburn, M. V., Rosenfeld, M. G., & Glass, C. K. (1998) · Nature · doi:10.1038/26040 · Cited by 336
Borruel, N., Carol, M., Casellas, F., Antolín, M., de Lara, F., Espín, E., Naval, J., Guarner, F., & Malagelada, J. R. (2002) · Gut · doi:10.1136/gut.51.5.659 · Cited by 326
A Unique PPARγ Ligand with Potent Insulin-Sensitizing yet Weak Adipogenic Activity
Rocchi, S., Picard, F., Vamecq, J., Gelman, L., Potier, N., Zeyer, D., Dubuquoy, L., Bac, P., Champy, M.-F., Plunket, K. D., et al. (2001) · Molecular Cell · doi:10.1016/s1097-2765(01)00353-7 · Cited by 272
Self-citationPPARadigms and PPARadoxes: expanding roles for PPARγ in the control of lipid metabolism
Walczak, R., & Tontonoz, P. (2002) · Journal of Lipid Research · doi:10.1016/s0022-2275(20)30159-0 · Cited by 270
Ameho, C. K., Adjei, A. A., Harrison, E. K., Takeshita, K., Morioka, T., Arakaki, Y., Ito, E., Suzuki, I., Kulkarni, A. D., Kawajiri, A., et al. (1997) · Gut · doi:10.1136/gut.41.4.487 · Cited by 234
Kaiser, G. C., Yan, F., & Polk, D. B. (1999) · Gastroenterology · doi:10.1016/s0016-5085(99)70182-4 · Cited by 234
Egan, L. J., Mays, D. C., Huntoon, C. J., Bell, M. P., Pike, M. G., Sandborn, W. J., Lipsky, J. J., & McKean, D. J. (1999) · Journal of Biological Chemistry · doi:10.1074/jbc.274.37.26448 · Cited by 217
Endogenous PPARγ mediates anti-inflammatory activity in murine ischemia-reperfusion injury
Nakajima, A., Wada, K., Miki, H., Kubota, N., Nakajima, N., Terauchi, Y., Ohnishi, S., Saubermann, L. J., Kadowaki, T., Blumberg, R. S., et al. (2001) · Gastroenterology · doi:10.1053/gast.2001.21191 · Cited by 216
Target Genes of Peroxisome Proliferator-activated Receptor γ in Colorectal Cancer Cells
Gupta, R. A., Brockman, J. A., Sarraf, P., Willson, T. M., & DuBois, R. N. (2001) · Journal of Biological Chemistry · doi:10.1074/jbc.m103779200 · Cited by 215
Dubuquoy, L., Dharancy, S., Nutten, S., Pettersson, S., Auwerx, J., & Desreumaux, P. (2002) · The Lancet · doi:10.1016/s0140-6736(02)11395-x · Cited by 198
Self-citationKatayama, K., Wada, K., Nakajima, A., Mizuguchi, H., Hayakawa, T., Nakagawa, S., Kadowaki, T., Nagai, R., Kamisaki, Y., Blumberg, R. S., et al. (2003) · Gastroenterology · doi:10.1016/s0016-5085(03)00262-2 · Cited by 176
Brown, K. K., Henke, B. R., Blanchard, S. G., Cobb, J. E., Mook, R., Kaldor, I., Kliewer, S. A., Lehmann, J. M., Lenhard, J. M., Harrington, W. W., et al. (1999) · Diabetes · doi:10.2337/diabetes.48.7.1415 · Cited by 172
Philippe, D., Dubuquoy, L., Groux, H., Brun, V., Chuoï-Mariot, M. T. V., Gaveriaux-Ruff, C., Colombel, J.-F., Kieffer, B. L., & Desreumaux, P. (2003) · Journal of Clinical Investigation · doi:10.1172/jci16750 · Cited by 171
Self-citationLefebvre, M., Paulweber, B., Fajas, L., Woods, J., McCrary, C., Colombel, J., Najib, J., Fruchart, J., Datz, C., Vidal, H., et al. (1999) · Journal of Endocrinology · doi:10.1677/joe.0.1620331 · Cited by 167
Self-citationThe mode of action of the aminosalicylates in inflammatory bowel disease
Greenfield, S., Punchard, N. A., TEARE, J. P., & Thompson, R. P. H. (1993) · Alimentary Pharmacology & Therapeutics · doi:10.1111/j.1365-2036.1993.tb00110.x · Cited by 162
Wadworth, A. N., & Fitton, A. (1991) · Drugs · doi:10.2165/00003495-199141040-00009 · Cited by 110
Mesalazine causes a mitotic arrest and induces caspase-dependent apoptosis in colon carcinoma cells
Reinacher‐Schick, A. (2003) · Carcinogenesis · doi:10.1093/carcin/24.3.443 · Cited by 107
Intestinal Metabolism and Transport of 5-Aminosalicylate
Zhou, S. Y., Fleisher, D., Pao, L., Li, C., Winward, B., & Zimmermann, E. M. (1999) · Drug Metabolism and Disposition · doi:10.1016/s0090-9556(24)15210-5 · Cited by 98
Yan, F., & Polk, D. B. (1999) · Journal of Biological Chemistry · doi:10.1074/jbc.274.51.36631 · Cited by 85
Brogden, R. N., & Sorkin, E. M. (1989) · Drugs · doi:10.2165/00003495-198938040-00003 · Cited by 83
Misra, P., Owuor, E. D., Li, W., Yu, S., Qi, C., Meyer, K., Zhu, Y.-J., Rao, M. S., Kong, A.-N. T., & Reddy, J. K. (2002) · Journal of Biological Chemistry · doi:10.1074/jbc.m208829200 · Cited by 75
Shibuya, A., Wada, K., Nakajima, A., Saeki, M., Katayama, K., Mayumi, T., Kadowaki, T., Niwa, H., & Kamisaki, Y. (2002) · FEBS Letters · doi:10.1016/s0014-5793(02)03059-4 · Cited by 75
Differential Gene Regulation by PPARγ Agonist and Constitutively Active PPARγ2
Li, Y., & Lazar, M. A. (2002) · Molecular Endocrinology · doi:10.1210/mend.16.5.0825 · Cited by 66
Regulation of Peroxisome Proliferator-activated Receptor-γ-mediated Gene Expression
Han, J., Hajjar, D. P., Zhou, X., Gotto, A. M., & NICHOLSON, A. C. (2002) · Journal of Biological Chemistry · doi:10.1074/jbc.m200685200 · Cited by 59
What dose of 5-aminosalicylic acid (mesalazine) in ulcerative colitis?
Riley, S. A. (1998) · Gut · doi:10.1136/gut.42.6.761 · Cited by 59
Selective Intranuclear Redistribution of PPAR Isoforms by RXR
Akiyama, T. E., Baumann, C. T., Sakai, S., Hager, G. L., & Gonzalez, F. J. (2002) · Molecular Endocrinology · doi:10.1210/mend.16.4.0797 · Cited by 50
Differential Gene Regulation by PPAR Agonist and Constitutively Active PPAR 2
Li, Y. (2002) · Molecular Endocrinology · doi:10.1210/me.16.5.1040 · Cited by 44
Structural Determinants of the Ligand-Binding Site of the Human Retinoic Acid Receptor .alpha.
Lefebvre, B., Rachez, C., Formstecher, P., & Lefèbvre, P. (1995) · Biochemistry · doi:10.1021/bi00016a019 · Cited by 26
Self-citationLefebvre, B., Mouchon, A., Formstecher, P., & Lefèbvre, P. (1998) · Molecular and Cellular Endocrinology · doi:10.1016/s0303-7207(98)00065-3 · Cited by 11
Self-citation
Cited by
Ungaro, R., Mehandru, S., Allen, P. B., Peyrin-Biroulet, L., & Colombel, J.-F. (2017) · The Lancet · doi:10.1016/s0140-6736(16)32126-2 · Cited by 3,531
Self-citationFat and Beyond: The Diverse Biology of PPARγ
Tontonoz, P., & Spiegelman, B. M. (2008) · Annual Review of Biochemistry · doi:10.1146/annurev.biochem.77.061307.091829 · Cited by 2,085
Kaser, A., Zeissig, S., & Blumberg, R. S. (2010) · Annual Review of Immunology · doi:10.1146/annurev-immunol-030409-101225 · Cited by 1,806
Mechanisms of Disease: pathogenesis of Crohn's disease and ulcerative colitis
Sartor, R. B. (2006) · Nature Clinical Practice Gastroenterology & Hepatology · doi:10.1038/ncpgasthep0528 · Cited by 1,757
International Union of Pharmacology. LXI. Peroxisome Proliferator-Activated Receptors
Michalik, L., Auwerx, J., Berger, J. P., Chatterjee, V. K., Glass, C. K., Gonzalez, F. J., Grimaldi, P. A., Kadowaki, T., Lazar, M. A., O’Rahilly, S., et al. (2006) · Pharmacological Reviews · doi:10.1124/pr.58.4.5 · Cited by 1,000
Self-citation
Metadata
- Authors
- Rousseaux, C., Lefebvre, B., Dubuquoy, L., Lefebvre, P., Romano, O., Auwerx, J., Metzger, D., Wahli, W., Desvergne, B., Naccari, G. C., Chavatte, P., Farce, A., Bulois, P., Cortot, A., Colombel, J. F., & Desreumaux, P.
- Venue
- The Journal of Experimental Medicine
- Publisher
- Rockefeller University Press
- Published
- 2005-04-11
- Volume
- 201
- Issue
- 8
- Pages
- 1205-1215
- ISSN
- 0022-1007 (ISSN-L)
- 1540-9538
- OpenAlex
- W2137537116
- Cited by
- 526
- References
- 55
- FWCI
- 10.26
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.